• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加那利群岛慢性阻塞性肺疾病患者的心血管合并症(CCECAN研究)。

Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).

作者信息

Figueira Gonçalves Juan Marco, Dorta Sánchez Rafael, Rodri Guez Pérez María Del Cristo, Viña Manrique Pedro, Díaz Pérez David, Guzmán Saenz Cristina, Palmero Tejera Juan Manuel, Pérez Rodríguez Alicia, Pérez Negrín Lorenzo

机构信息

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de La Candelaria, Santa Cruz de Tenerife, España.

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de La Candelaria, Santa Cruz de Tenerife, España.

出版信息

Clin Investig Arterioscler. 2017 Jul-Aug;29(4):149-156. doi: 10.1016/j.arteri.2017.01.003. Epub 2017 Apr 5.

DOI:10.1016/j.arteri.2017.01.003
PMID:28390852
Abstract

INTRODUCTION

Numerous studies have shown a high prevalence of cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). The aim of this study was to analyse the prevalence of cardiovascular risk factors and comorbidity in a Canary Islands population diagnosed with COPD, and compared it with data from the general population.

PATIENTS AND METHODS

A cross-sectional study was carried out in 300 patients with COPD and 524 subjects without respiratory disease (control group). The two groups were compared using standard bivariate methods. Logistic regression models were used to estimate the cardiovascular risks in COPD patients compared to control group.

RESULTS

Patients with COPD showed a high prevalence of hypertension (72%), dyslipidaemia (73%), obesity (41%), diabetes type 2 (39%), and sleep apnoea syndrome (30%) from mild stages of the disease (GOLD 2009). There was a 22% prevalence of cardiac arrhythmia, 16% of ischaemic heart disease, 16% heart failure, 12% peripheral vascular disease, and 8% cerebrovascular disease. Compared to the control group, patients with COPD had a higher risk of dyslipidaemia (OR 3.24, 95% CI; 2.21-4.75), diabetes type 2 (OR 1.52, 95% CI; 1.01-2,28), and ischaemic heart disease (OR 2.34, 95% CI; 1.22-4.49). In the case of dyslipidaemia, an increased risk was obtained when adjusted for age, gender, and consumption of tobacco (OR 5.04, 95% CI; 2.36-10.74).

CONCLUSIONS

Patients with COPD resident in the Canary Islands have a high prevalence of hypertension, dyslipidaemia, ischaemic heart disease, and cardiac arrhythmia. Compared to general population, patients with COPD have a significant increase in the risk of dyslipidaemia.

摘要

引言

众多研究表明,慢性阻塞性肺疾病(COPD)患者中心血管疾病的患病率很高。本研究的目的是分析加那利群岛诊断为COPD的人群中心血管危险因素和合并症的患病率,并将其与普通人群的数据进行比较。

患者与方法

对300例COPD患者和524例无呼吸系统疾病的受试者(对照组)进行了横断面研究。使用标准双变量方法对两组进行比较。采用逻辑回归模型估计COPD患者与对照组相比的心血管风险。

结果

COPD患者中高血压(72%)、血脂异常(73%)、肥胖(41%)、2型糖尿病(39%)和睡眠呼吸暂停综合征(30%)在疾病轻度阶段(GOLD 2009)的患病率很高。心律失常患病率为22%,缺血性心脏病为16%,心力衰竭为16%,外周血管疾病为12%,脑血管疾病为8%。与对照组相比,COPD患者血脂异常(OR 3.24,95%CI;2.21-4.75)、2型糖尿病(OR 1.52,95%CI;1.01-2.28)和缺血性心脏病(OR 2.34,95%CI;1.22-4.49)的风险更高。就血脂异常而言,在调整年龄、性别和烟草消费后风险增加(OR 5.04,95%CI;2.36-10.74)。

结论

居住在加那利群岛的COPD患者中高血压、血脂异常、缺血性心脏病和心律失常的患病率很高。与普通人群相比,COPD患者血脂异常的风险显著增加。

相似文献

1
Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).加那利群岛慢性阻塞性肺疾病患者的心血管合并症(CCECAN研究)。
Clin Investig Arterioscler. 2017 Jul-Aug;29(4):149-156. doi: 10.1016/j.arteri.2017.01.003. Epub 2017 Apr 5.
2
Prevalence of chronic obstructive pulmonary disease in the Canary Islands.加那利群岛慢性阻塞性肺疾病的患病率。
Arch Bronconeumol. 2014 Jul;50(7):272-7. doi: 10.1016/j.arbres.2013.12.006. Epub 2014 Feb 4.
3
Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study.家庭医学中慢性阻塞性肺疾病患者的合并症:一项横断面研究。
BMC Fam Pract. 2013 Jan 16;14:11. doi: 10.1186/1471-2296-14-11.
4
Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.在五个拉丁美洲城市中,有和没有 COPD 的个体的合并症和健康状况:PLATINO 研究。
Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13.
5
Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).慢性阻塞性肺疾病作为心血管疾病的危险因素。一项病例对照研究(CONSISTE 研究)的结果。
Int J Chron Obstruct Pulmon Dis. 2012;7:679-86. doi: 10.2147/COPD.S36222. Epub 2012 Oct 1.
6
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.当考虑到经典心血管危险因素时,缺血性心脏病与 COPD 并无关联。
Int J Chron Obstruct Pulmon Dis. 2010 Nov 8;5:387-94. doi: 10.2147/copd.s14063.
7
[The continuum of COPD and cardiovascular risk: A global scenario of disease].慢性阻塞性肺疾病与心血管风险的连续统一体:全球疾病状况
Clin Investig Arterioscler. 2015 May-Jun;27(3):144-7. doi: 10.1016/j.arteri.2014.09.003. Epub 2014 Dec 10.
8
Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者心血管合并症的风险:系统评价和荟萃分析。
Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22.
9
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.加拿大萨斯喀彻温省慢性阻塞性肺疾病患者的心血管疾病,慢性阻塞性肺疾病患者的心血管疾病
Ann Epidemiol. 2006 Jan;16(1):63-70. doi: 10.1016/j.annepidem.2005.04.008. Epub 2005 Jul 21.
10
[Ischaemic heart disease and hypertension in patients with chronic obstructive pulmonary disease and obstructive sleep apnoea].慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停患者的缺血性心脏病与高血压
Pneumonol Alergol Pol. 2013;81(6):567-74.

引用本文的文献

1
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.慢性阻塞性肺疾病患者发生缺血性心脏病的风险:一项全国性队列研究。
J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.